Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00UBR
|
||||
| Former ID |
DNC013798
|
||||
| Drug Name |
Cyclohexylmethylcarbamic Acid Biphenyl-3-yl Ester
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529498] | ||
| Formula |
C20H23NO2
|
||||
| Canonical SMILES |
C1CCC(CC1)CNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3
|
||||
| InChI |
1S/C20H23NO2/c22-20(21-15-16-8-3-1-4-9-16)23-19-13-7-12-18(14-19)17-10-5-2-6-11-17/h2,5-7,10-14,16H,1,3-4,8-9,15H2,(H,21,22)
|
||||
| InChIKey |
AARHPAICPBZNBZ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529498] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.